Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study

Teferi Gebru Gebremeskel,1 Destalem Gebreyowhans,2 Hailay Abrha Gesesew,3,4 Paul R Ward3 1Department of Reproductive Health, College of Health Sciences, Aksum University, Aksum, Ethiopia; 2School of Medicine, College of Medicine and Health Science, Aksum University, Aksum, Ethiopia; 3Discipline of P...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Gebremeskel TG, Gebreyowhans D, Gesesew HA, Ward PR
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	human immunodeficiency virus adverse drug reactions antiretroviral therapy. Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/0733457eec5b4c0aa0f2f96e5ca35f45
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0733457eec5b4c0aa0f2f96e5ca35f45
record_format	dspace
spelling	oai:doaj.org-article:0733457eec5b4c0aa0f2f96e5ca35f452021-12-02T17:37:20ZIncidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study1179-1373https://doaj.org/article/0733457eec5b4c0aa0f2f96e5ca35f452021-06-01T00:00:00Zhttps://www.dovepress.com/incidence-and-predictors-of-severe-adverse-drug-reaction-among-patient-peer-reviewed-fulltext-article-HIVhttps://doaj.org/toc/1179-1373Teferi Gebru Gebremeskel,1 Destalem Gebreyowhans,2 Hailay Abrha Gesesew,3,4 Paul R Ward3 1Department of Reproductive Health, College of Health Sciences, Aksum University, Aksum, Ethiopia; 2School of Medicine, College of Medicine and Health Science, Aksum University, Aksum, Ethiopia; 3Discipline of Public Health, Flinders University, Adelaide, South Australia, Australia; 4Department of Epidemiology, College of Health Sciences, Mekele University, Mekele, EthiopiaCorrespondence: Teferi Gebru Gebremeskel Email teferigebru12@gmail.comBackground: The aim of the present study was to assess the incidence and predictors of severe adverse drug reactions among patients on antiretroviral therapy (ART) in Tigray, North Ethiopia.Methods: We employed four years retrospective cohort study using a structured data extraction sheet. The study populations were HIV patients on ART follow-up from January 2017 to February 2020 in the study area. Severe adverse drug reaction (ADR) was an outcome variable and defined as having any one of the complaints related to ARV drug reaction due to regimen change, discontinuation, and/or in-patient care. Data were collected using a structured data extraction sheet. A Cox proportional hazard regression model was used to determine the relationship between the predictors and the outcome variable. The mean survival time of the cohort was estimated using the Kaplan–Meier method.Results: The incidence rate of ADRs was 3.6 (95%CI: 2.9– 4.35) per 100-person years. HIV patients with no formal education (adjusted hazard ratio=1.58, 95%CI: 1.03– 2.41), with experience of regimen change (adjusted hazard ratio=1.59, 95%CI: 1.12– 2.91), who ever took other medication (adjusted hazard ratio=1.49, 95%CI: 1.05– 2.15) and with lower body mass index (adjusted hazard ratio=3.24, 95%CI: 1.18– 4.91) were more likely to develop severe adverse drug reaction.Conclusion: ADRs were diagnosed an inconsiderable number of HIV patients on ART and factors were patient and drug-related. To minimize it, special attention is sought for patients with no formal education, previous regime change, whoever took other medication, and who have lower body mass index levels.Keywords: human immunodeficiency virus, adverse drug reactions, antiretroviral therapyGebremeskel TGGebreyowhans DGesesew HAWard PRDove Medical Pressarticlehuman immunodeficiency virusadverse drug reactionsantiretroviral therapy.Immunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol Volume 13, Pp 641-649 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	human immunodeficiency virus adverse drug reactions antiretroviral therapy. Immunologic diseases. Allergy RC581-607
spellingShingle	human immunodeficiency virus adverse drug reactions antiretroviral therapy. Immunologic diseases. Allergy RC581-607 Gebremeskel TG Gebreyowhans D Gesesew HA Ward PR Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
description	Teferi Gebru Gebremeskel,1 Destalem Gebreyowhans,2 Hailay Abrha Gesesew,3,4 Paul R Ward3 1Department of Reproductive Health, College of Health Sciences, Aksum University, Aksum, Ethiopia; 2School of Medicine, College of Medicine and Health Science, Aksum University, Aksum, Ethiopia; 3Discipline of Public Health, Flinders University, Adelaide, South Australia, Australia; 4Department of Epidemiology, College of Health Sciences, Mekele University, Mekele, EthiopiaCorrespondence: Teferi Gebru Gebremeskel Email teferigebru12@gmail.comBackground: The aim of the present study was to assess the incidence and predictors of severe adverse drug reactions among patients on antiretroviral therapy (ART) in Tigray, North Ethiopia.Methods: We employed four years retrospective cohort study using a structured data extraction sheet. The study populations were HIV patients on ART follow-up from January 2017 to February 2020 in the study area. Severe adverse drug reaction (ADR) was an outcome variable and defined as having any one of the complaints related to ARV drug reaction due to regimen change, discontinuation, and/or in-patient care. Data were collected using a structured data extraction sheet. A Cox proportional hazard regression model was used to determine the relationship between the predictors and the outcome variable. The mean survival time of the cohort was estimated using the Kaplan–Meier method.Results: The incidence rate of ADRs was 3.6 (95%CI: 2.9– 4.35) per 100-person years. HIV patients with no formal education (adjusted hazard ratio=1.58, 95%CI: 1.03– 2.41), with experience of regimen change (adjusted hazard ratio=1.59, 95%CI: 1.12– 2.91), who ever took other medication (adjusted hazard ratio=1.49, 95%CI: 1.05– 2.15) and with lower body mass index (adjusted hazard ratio=3.24, 95%CI: 1.18– 4.91) were more likely to develop severe adverse drug reaction.Conclusion: ADRs were diagnosed an inconsiderable number of HIV patients on ART and factors were patient and drug-related. To minimize it, special attention is sought for patients with no formal education, previous regime change, whoever took other medication, and who have lower body mass index levels.Keywords: human immunodeficiency virus, adverse drug reactions, antiretroviral therapy
format	article
author	Gebremeskel TG Gebreyowhans D Gesesew HA Ward PR
author_facet	Gebremeskel TG Gebreyowhans D Gesesew HA Ward PR
author_sort	Gebremeskel TG
title	Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
title_short	Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
title_full	Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
title_fullStr	Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
title_full_unstemmed	Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
title_sort	incidence and predictors of severe adverse drug reaction among patients on antiretroviral therapy in tigray, ethiopia: a retrospective cohort study
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/0733457eec5b4c0aa0f2f96e5ca35f45
work_keys_str_mv	AT gebremeskeltg incidenceandpredictorsofsevereadversedrugreactionamongpatientsonantiretroviraltherapyintigrayethiopiaaretrospectivecohortstudy AT gebreyowhansd incidenceandpredictorsofsevereadversedrugreactionamongpatientsonantiretroviraltherapyintigrayethiopiaaretrospectivecohortstudy AT gesesewha incidenceandpredictorsofsevereadversedrugreactionamongpatientsonantiretroviraltherapyintigrayethiopiaaretrospectivecohortstudy AT wardpr incidenceandpredictorsofsevereadversedrugreactionamongpatientsonantiretroviraltherapyintigrayethiopiaaretrospectivecohortstudy
_version_	1718379863296966656

Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study

Ejemplares similares